PHI/CDC Global Health Fellowship and ASPPH/CDC Allan Rosenfield Global Health Fellowship, Atlanta, USA.
Centers for Disease Control and Prevention, Atlanta, USA.
Vaccine. 2019 Oct 3;37 Suppl 1(Suppl 1):A14-A19. doi: 10.1016/j.vaccine.2018.10.011. Epub 2018 Oct 9.
There are approximately 35,000 human deaths from rabies in Asia annually. Rabies can be prevented through timely post-exposure prophylaxis (PEP) consisting of wound washing, rabies vaccine, and in some cases, rabies immunoglobulin (RIG). However, access to rabies PEP often remains limited to urban areas and is cost-prohibitive. There is little information on procurement, distribution, monitoring, and reporting of rabies PEP.
We interviewed key informants in the public sector from various levels in Bangladesh, Bhutan, Cambodia, and Sri Lanka between March 2017 and May 2018 using a descriptive assessment tool to obtain information on procurement, distribution, monitoring, and reporting of rabies PEP. These four countries in Asia were chosen to showcase a range of rabies PEP systems. National rabies focal points were interviewed in each country and focal points helped identify additional key informants at lower levels.
A total of 22 key informants were interviewed at various levels (central level to health facility level) including national rabies focal points in each country. Each country has a unique system for managing rabies PEP procurement, distribution, monitoring, and reporting. There are varying levels of PEP access for those with potential rabies exposures. Rabies PEP is available in select health facilities throughout the country in Bangladesh, Bhutan, and Sri Lanka. In Cambodia, rabies PEP is limited to two urban centers. The availability of RIG in all four countries is limited. In these four countries, most aspects of the rabies PEP distribution system operate independently of systems for other vaccines. However, in Bhutan, rabies PEP and Expanded Programme on Immunization (EPI) vaccines share cold chain space in some locations at the lowest level. All countries have a monitoring system in place, but there is limited reporting of data, particularly to the central level.
Systems to procure, deliver, monitor, and report on rabies PEP are variable across countries. Sharing information on practices more widely among countries can help programs to increase access to this life-saving treatment.
亚洲每年约有 35000 人死于狂犬病。通过及时的暴露后预防(PEP),包括伤口清洗、狂犬病疫苗,以及在某些情况下使用狂犬病免疫球蛋白(RIG),可以预防狂犬病。然而,狂犬病 PEP 的获得往往仍然局限于城市地区,而且费用昂贵。有关狂犬病 PEP 的采购、分发、监测和报告的信息很少。
我们于 2017 年 3 月至 2018 年 5 月间在孟加拉国、不丹、柬埔寨和斯里兰卡的公共部门各级别对关键知情者进行了访谈,使用描述性评估工具获取有关狂犬病 PEP 的采购、分发、监测和报告的信息。这四个亚洲国家展示了不同的狂犬病 PEP 系统。每个国家都采访了国家狂犬病协调员,并由协调员帮助确定了较低级别下的其他关键知情者。
总共在各级别(中央级别到卫生机构级别)采访了 22 名关键知情者,包括每个国家的国家狂犬病协调员。每个国家都有独特的管理狂犬病 PEP 采购、分发、监测和报告的系统。潜在狂犬病暴露者的 PEP 获得情况也各不相同。在孟加拉国、不丹和斯里兰卡,狂犬病 PEP 可在全国部分卫生机构获得。在柬埔寨,狂犬病 PEP 仅限于两个城市中心。这四个国家的 RIG 供应都很有限。在这四个国家,狂犬病 PEP 分发系统的大多数方面都独立于其他疫苗系统运行。然而,在不丹,狂犬病 PEP 和扩大免疫规划(EPI)疫苗在最低级别某些地点共享冷链空间。所有国家都有监测系统,但数据报告有限,特别是向中央级别的报告。
各国采购、提供、监测和报告狂犬病 PEP 的系统各不相同。在国家之间更广泛地分享实践信息,可以帮助各项目增加获得这种救命治疗的机会。